BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES

Similar documents
Step Therapy Criteria 2019

Quarterly pharmacy formulary change notice

May 2016 P & T Updates

Topical Immunomodulators

Quarterly Pharmacy Formulary Change Notice

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

The Medical Letter. on Drugs and Therapeutics

Effective for all members on August 1, 2017

Comparison of representative topical corticosteroid preparations (classified according to the US system)

2017 Formulary Changes Year to Date

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

HIV Drugs and the HIV Lifecycle

Step Therapy Requirements

Emblem Medicaid 4th Quarter Formulary Updates

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

Eucrisa. Eucrisa (crisaborole) Description

2018 Step Therapy (ST) Criteria

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Michigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Appropriate Use & Safety Edits

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Eucrisa. Eucrisa (crisaborole) Description

Step Therapy Requirements

The safety and effectiveness of Dupixent in pediatric patients have not been established (1).

Antiretrovial Crushable/Liquid Formulation Chart

HIV medications HIV medication and schedule plan

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

Drug Class Literature Scan: Topical Steroids

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

Topical Immunomodulators

Prior Authorization Topical Immunomodulators Elidel and Protopic 0.03%

Update to HMO Drug Formulary Tier Definitions. February 8, 2018

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care

Comparison of representative topical corticosteroid preparations (classified according to the US system)


BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES

Midwestern Underwriting Conference 2016

HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ALLERGIC RHINITIS-NASAL

FLORIDA!A MEDICAID' Better Health Care for all Floridians. May

See Important Reminder at the end of this policy for important regulatory and legal information.

OB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

See Important Reminder at the end of this policy for important regulatory and legal information.

2018 CareOregon Advantage Part D Formulary Changes

Antiretroviral Dosing in Renal Impairment

Pharmacy Benefit Determination Policy

Genotyping and Drug Resistance in Clinical Practice. Case Studies

Dupixent (dupilumab)

Antipsychotic Medications Age and Step Therapy

Medscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection

HIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Drug Formulary Update, July 2016 Commercial and State Programs

ANTICONVULSANT THERAPY

Children s Hospital Of Wisconsin

Step Therapy Requirements. Effective: 12/01/2016

FirstCarolinaCare Insurance Company Step Therapy Requirements

ANTIRETROVIRAL TREATMENTS (Part 1of

PPHP 2017 Formulary 2017 Step Therapy Criteria

HIV and YOU. Special 2008 Update!

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

Step Therapy Medications

HIV Infection & AIDS in Low- and Middle-Income Countries

Pharmacy Medical Necessity Guidelines: Atypical Antipsychotic Medications. Effective: February 20, 2017

AIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010

Pharmacologic Treatment of Atopic Dermatitis

Pharmacy Medical Necessity Guidelines: Atypical Antipsychotic Medications. Effective: December 12, 2017

Adherence Strategies for Older Adults. AIDS Community Research Initiative of America (ACRIA)

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary

LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

BlueLink TPA FlexRx Updates

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 May 2012

BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search

ANTIDIABETIC AGENTS - MISCELLANEOUS

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications

ADAP Monitoring Provider Prescribing Patterns. Amanda Bowes, NASTAD Christine Rivera and Dr. Charles Gonzalez, NYS AIDS Institute

Blue Medicare HMO Essential 2015 Quantity Limit List Blue Medicare Rx Standard 2015 Quantity Limit List

TennCare Program TN MAC Price Change List As of: 03/30/2017

ADHD STIMULANTS-S(SHC)

UnitedHealthcare Community Plan PDL Modifications. Added as an alternative agent for the 9/1/ /1/2012

Transcription:

BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies. Our Pharmacy and Therapeutics (P&T) Committee is made up of a group of practicing physicians and pharmacists who meet quarterly to recommend changes to our formulary based on the latest medical literature, new clinical guidelines, new information from key physician experts, and new information from the Food and Drug Administration. Changes to the Standard Drug Formulary from the P&T Committee meeting are outlined below. To view a copy of the Standard Drug Formulary, please download a copy. The drugs listed below are to be used for FDA-approved indications but may also be used for other conditions. 1. DRUGS ADDED TO FORMULARY The following drugs were added to the formulary: Drug FDA Indication(s) Coverage Restriction(s) Tier Status cyclopentolate 2% drops (generic Cyclogyl) fluticasone propionate (generic Flonase) metformin extendedrelease tablet (generic Glumetza) naftifine 2% cream (generic Naftin) naloxone 0.4mg/ml vial and syringe, 2mg/2ml syringe norgestimate-ethinyl estradiol, tri-lo-sprintec, tri-lo-estarylla, trinessa lo, tri-lo-marzia (generic Ortho Tri-Cyclen Lo) olopatadine 0.1% drops (generic Patanol) Otezla Praluent pramipexole 2.25mg extended-release (generic Mirapex ER) Tanzeum Mydriasis, Cycloplegia Allergic and non-allergic rhinitis Tinea pedis, Tinea cruris, Tinea corporis Prior authorization required. Step therapy required Opioid overdose Add quantity limit Prevent pregnancy Allergic conjunctivitis Psoriatic arthritis, Plaque psoriasis Hypercholesterolemia Prior authorization required, Prior authorization required, Tier 4 # Tier 4 # Parkinson s disease Step therapy required, Page 1 of 6

Drug FDA Indication(s) Coverage Restriction(s) Tier Status Toujeo Solostar Diabetes # must be obtained through a network specialty pharmacy Tier 2 (effective 1/1/2017) 2. FORMULARY DRUGS WITH CHANGES TO TIER AND/OR COVERAGE RESTRICTION The following drugs have coverage restriction(s) added or removed, and/or change of tier status as noted: DRUG FDA Indication(s) Coverage Restriction(s) Tier Status aripiprazole (generic Abilify) tablet, solution mania, Depression, Autistic, Tourette s Add quantity limit Azilect Parkinson s disease budesonide (generic Entocort EC) clobetasol (generic Clobex) lotion clobetasol (generic Clobex) shampoo Crohn s disease Corticosteroid responsive, Plaque psoriasis, quantity limit (effective 2017) Step therapy required Tier 2 Scalp psoriasis Step therapy required clozapine odt (generic Fazaclo) Schizophrenia dihydroergotamine mesylate (generic D.H.E. 45) dihydroergotamine (generic Migranal) nasal Epivir HBV solution exemestane (generic Aromasin) fluocinolone (generic Synalar) solution lamivudine (generic Epivir HBV) tablet metformin extended-release (generic Fortamet) phenoxybenzamine (generic Dibenzyline) Migraine, Cluster headache Migraine Hepatitis B Breast cancer Corticosteroid responsive Hepatitis B Pheochromocytoma Prior authorization required. Add step therapy.. Remove prior authorization. Remove age and gender edit Add step therapy. Remove prior authorization Tier 4 Tier 4 Tier 2 Page 2 of 6

risperidone odt (generic Risperdal M-Tab) ziprasidone (generic Geodon) Anti-retrovirals abacavir (generic Ziagen) tablet abacavir/lamivudine/zidovudine (generic Trizivir), Autistic HIV infection Add quantity limit HIV infection Add quantity limit Atripla HIV infection Add quantity limit Complera HIV infection Add quantity limit Crixivan HIV infection Add quantity limit Tier 2 didanosine (generic Videx EC) HIV infection Add quantity limit Edurant HIV infection Add quantity limit Tier 2 Emtriva HIV infection Add quantity limit Tier 2 Epzicom HIV infection Add quantity limit Tier 2 Intelence HIV infection Step therapy required. Add quantity limit Tier 2 Invirase HIV infection Add quantity limit Tier 2 Isentress HIV infection Add quantity limit Tier 2 Kaletra HIV infection Add quantity limit Tier 2 lamivudine (generic Epivir) HIV infection Add quantity limit lamivudine/zidovudine (generic Combivir) HIV infection Add quantity limit Lexiva HIV infection Add quantity limit Tier 2 nevirapine (generic Viramune) HIV infection Add quantity limit nevirapine extende-release (generic Viramune R) HIV infection Add quantity limit Norvir HIV infection Add quantity limit Tier 2 Prezista HIV infection Add quantity limit Tier 2 Rescriptor HIV infection Add quantity limit Tier 2 Reyataz capsule HIV infection Add quantity limit Tier 2 Selzentry HIV infection Prior authorization required. Add quantity limit Tier 2 stavudine (generic Zerit) HIV infection Add quantity limit Sustiva HIV infection Add quantity limit Tier 2 Truvada HIV infection Add quantity limit Tier 2 Page 3 of 6

Viracept HIV infection Add quantity limit Tier 2 zidovudine (generic Retrovir) capsule, syrup HIV infection Add quantity limit 3. DRUGS REMOVED FROM THE FORMULARY The following drugs will be removed from the formulary starting January 2017. Non-formulary drugs require a formulary exception based on medical necessity for coverage. Drug FDA Indication(s) Formulary Alternative(s) Bydureon, Bydureon pen, Byetta metformin, sulfonylurea, TZD, Tanzeum (steptherapy required) Glucophage metformin (generic Glucophage) Glucophage XR metformin extended release (generic Glucophage XR) Glucovance glyburide/metformin (generic Glucovance) Kasano, Nesina, Oseni Kombiglyze XR, Onglyza Latuda Januvia, Janumet (step therapy required for both) Januvia, Janumet (step therapy required for both) olanzapine, quetiapine, risperidone Levemir, Levemir Flextouch Diabetes Lantus, Toujeo metformin extended-release (generic Fortamet) metformin extended-release (generic Glucophage XR) Nasonex Allergic rhinitis fluticasone nasal Nuvigil olanzapine-fluoxetine (generic Symbyax) Saizen Saphris Seroquel XR Topical Corticosteroids Obstructive sleep apnea, Narcolepsy, Shift work Bipolar, Depression Growth hormone deficiency mania, Depression modafinil (PA required) olanzapine, quetiapine, risperidone Nutropin, Nutropin AQ (PA required) olanzapine, quetiapine, risperidone quetiapine (generic Seroquel) Page 4 of 6

Drug FDA Indication(s) Formulary Alternative(s) amcinonide cream, lotion, ApexiCon E betamethasone valerate (generic Luxiq) foam clobetasol (generic Clobex) spray Clodan clocortolone (generic Cloderm) cream desonide (generic Desowen) lotion desoximetasone (generic Topicort) 0.05% cream desoximetasone (generic Topicort) gel,, 0.25% cream diflorasone cream, fluocinolone (generic Derma- Smoothe-FS) body oil fluocinolone (generic Derma- Smoothe-FS) scalp oil fluticasone (generic Cutivate) lotion of the scalp Plaque psoriasis Scalp psoriasis Atopic dermatitis Scalp psoriasis fluocinonide 0.05% gel, cream,, solution; betamethasone augmented 0.05% cream, lotion,, gel fluocinonide 0.05% gel, cream,, solution; betamethasone augmented 0.05% cream, lotion,, gel, lotion; betamethasone valerate 0.1% cream,, lotion; TAC 0.1% cream,, lotion; fluticasone 0.05% cream, ; mometasone 0.1% cream, clobetasol cream,, solution, gel, cream emollient clobetasol cream,, solution, gel, cream emollient, lotion; betamethasone valerate 0.1% cream,, lotion; TAC 0.1% cream,, lotion; fluticasone 0.05% cream, ; mometasone 0.1% cream, hydrocortisone 2.5% cream,, lotion; alclometasone 0.05% cream,, lotion; betamethasone valerate 0.1% cream,, lotion; TAC 0.1% cream,, lotion; fluticasone 0.05% cream, ; mometasone 0.1% cream, fluocinonide 0.05% gel, cream,, solution; betamethasone augmented 0.05% cream, lotion,, gel betamethasone, augmented 0.05% lotion,, gel, cream hydrocortisone 2.5% cream,, lotion; alclometasone 0.05% cream, hydrocortisone 2.5% cream,, lotion; alclometasone 0.05% cream,, lotion; betamethasone valerate 0.1% cream,, lotion; TAC 0.1% cream,, lotion; fluticasone 0.05% cream, ; mometasone 0.1% cream, Page 5 of 6

Drug FDA Indication(s) Formulary Alternative(s) hydrocortisone butyrate/emollient (generic Locoid Lipocream) cream Scalacort triamcinolone acetonide (generic Kenalog) spray Trianex, lotion; betamethasone valerate 0.1% cream,, lotion; TAC 0.1% cream,, lotion; fluticasone 0.05% cream, ; mometasone 0.1% cream, hydrocortisone 2.5% cream,, lotion; alclometasone 0.05% cream,, lotion; betamethasone valerate 0.1% cream,, lotion; TAC 0.1% cream,, lotion; fluticasone 0.05% cream, ; mometasone 0.1% cream,, lotion; betamethasone valerate 0.1% cream,, lotion; TAC 0.1% cream,, lotion; fluticasone 0.05% cream, ; mometasone 0.1% cream, 4. DRUGS REMOVED FROM COVERAGE The following drugs were excluded from coverage because they are not approved by the Food and Drug Administration (FDA): Drug Ala-quin cream hydrocortisone-iodoquinol cream, cream pack Iodosorb gel Drug Nicomide Ultrasal ER Vytone Page 6 of 6